Screener
D&A at other companies
Other financials
Where this comes from
Reported directly by Organogenesis Holdings Inc. in its filing.
Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.
The source filing: Organogenesis Holdings Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:15 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338049
FAQ
- What is Organogenesis Holdings Inc.'s D&A?
- Organogenesis Holdings Inc. (ORGO) reported D&A of $3.67M in Q2 2026.
- How has Organogenesis Holdings Inc.'s D&A changed year-over-year?
- Organogenesis Holdings Inc.'s D&A decreased by 1.8% year-over-year, from $3.73M to $3.67M.
- What is the long-term trend for Organogenesis Holdings Inc.'s D&A?
- Over 4 years (2021 to 2025), Organogenesis Holdings Inc.'s D&A has grown at a 27.5% compound annual growth rate (CAGR), from $5.78M to $15.27M.
- What does D&A mean?
- Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.
Ask your AI about Organogenesis Holdings Inc.'s d&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude